Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer.

[1]  D. Heron,et al.  Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy. , 2006, Gynecologic oncology.

[2]  D. Heron,et al.  Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. , 2006, Gynecologic oncology.

[3]  Joseph K Salama,et al.  Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. , 2006, International journal of radiation oncology, biology, physics.

[4]  D. Heron,et al.  The Potential Nephrotoxic Effects of Intensity Modulated Radiotherapy Delivered to the Para-Aortic Area of Women With Gynecologic Malignancies: Preliminary Results , 2006, American journal of clinical oncology.

[5]  Dwight E Heron,et al.  Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. , 2005, International journal of radiation oncology, biology, physics.

[6]  John C Roeske,et al.  Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[7]  Jun Duan,et al.  IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. , 2004, International journal of radiation oncology, biology, physics.

[8]  P. Grigsby,et al.  Lymph node control in cervical cancer. , 2004, International journal of radiation oncology, biology, physics.

[9]  Sasa Mutic,et al.  Treatment planning guidelines regarding the use of CT/PET-guided IMRT for cervical carcinoma with positive paraaortic lymph nodes. , 2004, International journal of radiation oncology, biology, physics.

[10]  Mitchell Morris,et al.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  John C Roeske,et al.  Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. , 2003, International journal of radiation oncology, biology, physics.

[12]  B. Vikram,et al.  Extended‐field radiotherapy and high–dose‐rate brachytherapy in carcinoma of the uterine cervix , 2003, Cancer.

[13]  B. Vikram,et al.  Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer , 2002, International Journal of Gynecologic Cancer.

[14]  John C Roeske,et al.  Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[15]  F Dehdashti,et al.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  J. Roeske,et al.  Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. , 2001, Gynecologic oncology.

[17]  P. Grigsby,et al.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  B N Bundy,et al.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  B N Bundy,et al.  Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.

[20]  B N Bundy,et al.  Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. , 1999, The New England journal of medicine.

[21]  H. Averette,et al.  Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study. , 1998, International journal of radiation oncology, biology, physics.

[22]  H. Averette,et al.  5-year survival of patients with periaortic nodal metastases in clinical stage IB and IIA cervical carcinoma. , 1989, Gynecologic oncology.

[23]  B. Hilaris,et al.  The role of paraaortic node irradiation in the treatment of cancer of the cervix. , 1985, International journal of radiation oncology, biology, physics.

[24]  P. Disaia,et al.  Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). , 1984, Gynecologic oncology.

[25]  M. Piver,et al.  Five-year survival (with no evidence of disease) in patients with biopsy-confirmed aortic node metastasis from cervical carcinoma. , 1981, American journal of obstetrics and gynecology.

[26]  E. W. Bradley,et al.  Antherosclerosis and neoplasia in photon and neutron irradiated canines , 1980 .

[27]  J. Mikuta,et al.  Treatment of para‐aortic nodes in carcinoma of the cervix , 1975, Cancer.

[28]  P. Grigsby,et al.  Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. , 2001, International journal of radiation oncology, biology, physics.

[29]  P. Grigsby,et al.  Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10. , 1998, International journal of radiation oncology, biology, physics.

[30]  T. Pajak,et al.  Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. , 1995, JAMA.